MyoMapsAdd a new layer of pixel-based information on tissue composition.

MyoMaps
T1, T2 and T2* myocardial tissue quantification in one solution, on the fly.

Add a new layer of pixel-based quantative information to cardiac evaluation. Based on HeartFreeze Inline Motion Correction (Siemens unique), MyoMaps¹ provides pixel-based myocardial quantification, on the fly.

Designed to evolve visual assessment to pixel based quantification of tissue characteristics.
Based on Siemens-unique HeartFreeze Inline Motion Correction.
Support cardiovascular therapy, starting earlier and more efficiently.

Features & Benefits

Siemens takes the industry lead again with MyoMaps. Now, on the sound basis of fully system guided, HeartFreeze Inline Motion Correction, MyoMaps generates pixel-based T1, T2 and T2* colored parametric maps, providing you with an additional layer of quantitative information on tissue composition – on the fly.

Left: without motion correction. Right: HeartFreeze Inline Motion Correction

HeartFreeze
MyoMaps is based on Siemens-unique HeartFreeze Inline Motion Correction.

Comprehensive T1, T2, T2* Maps, all in one single application
Based on Siemens-unique HeartFreeze Inline Motion Correction

Clinical Use

MyoMaps¹ offers the possibility of acquiring pixel-based quantitative myocardial tissue characteristics. Robustly, efficiently, and on the fly.

MyoMaps has the clinical potential to help you assess myocardial pathologies with new information.

MRI - Applications - MyoMaps - T1 Map — Amyloidosis with MyoMaps; T1 Map (ms)
(Image: National Institutes of Health, Bethesda, USA)

Early clinical evidence:

New generation Cardiac Parametric Mapping: The Clinical Role of T1 and T2 Mapping.

Maestrini et al., MAGNETOM Flash 55, P. 104ff (pdf) 0.89 MB

Myocardial T1-Mapping: Techniques and Clinical Applications.

Fernandes, et al., MAGNETOM Flash 49, P. 96ff (pdf) 0.43 MB

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Moon et al., Journal of Cardiovascular Magnetic Resonance 2013, 15:92

"Myocardial T2 mapping is technically feasible and highly reproducible."

Wassmuth et al., Journal of Cardiovascular Magnetic Resonance 2013, 15:27

Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.

Pennell et al., Circulation., 128(3):281-308.

MAGNETOM World

Find relevant clinical information to optimize your daily work and alternative clinical approaches to grow and expand your practice in the worldwide community of MAGNETOM users.

General Requirements

System

Biograph mMR
MAGNETOM Aera
MAGNETOM Prisma
MAGNETOM Skyra
MAGNETOM Vida

Minimum Software Version

syngo MR E11

Other

Please Note: Additional technical prerequisites may apply. Upon receiving your request, your local Siemens representative will clarify whether your system meets the requirements.

Did this information help you?

The product may not be commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.